Related Experiment Video
Updated: May 29, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Liver interleukin-8 messenger RNA expression and interferon sensitivity-determining region mutations relate to
Chuan-Mo Lee1, Yi-Hao Yen, Chao-Hung Hung
1Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. chmolee@ms15.hinet.net
Background:
In vitro study has shown that mechanisms for inhibiting interferon (IFN)-α antiviral action by non-structural 5A protein include interaction with IFN-induced RNA-dependent protein kinase and induction of interleukin (IL)-8 expression. Mutations in the non-structural 5A IFN sensitivity-determining region (ISDR) were reported to correlate with sustained virological response (SVR). IL-8 is associated with the inhibition of IFN-α action. We investigated whether pretreatment ISDR mutations and hepatic IL-8 messenger RNA (mRNA) expression had an effect on the SVR rate under combination therapy.
Methods:
A total of 53 HCV-1b patients who completed 24 weeks of pegylated-IFN-α2b plus ribavirin, a 24-week follow-up and had enough tissue specimens were enrolled. Liver biopsy was performed within 6 months before antiviral therapy. Hepatic IL-8 mRNA expression was measured by real-time reverse transcriptase PCR.
Results:
Of 53 patients, 30 exhibited SVR. Multivariate analysis revealed that hepatic IL-8 mRNA expression <1.5×10(-4) (OR 6.66, 95% CI 1.77-25.05) and ISDR mutations ≥4 (OR 12.20, 95% CI 1.23-125.00) were independent predictors of SVR. Fibrosis scores and alanine aminotransferase levels were predictive of hepatic IL-8 mRNA expression by multiple linear regression analysis (r(2)=0.204).
Conclusions:
SVR to combination therapy in hepatitis C 1b patients was associated with down-regulated hepatic IL-8 mRNA expression and ISDR mutations. Fibrosis scores and alanine aminotransferase levels were predictive of hepatic IL-8 mRNA expression.
Insights
Hepatitis C patients achieving sustained virological response (SVR) with combination therapy showed lower interleukin-8 (IL-8) mRNA expression and more non-structural 5A protein mutations in the interferon sensitivity-determining region (ISDR). These factors independently predicted SVR success.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Interferon (IFN)-α antiviral action can be inhibited by non-structural 5A protein through interactions with IFN-induced RNA-dependent protein kinase and interleukin (IL)-8 expression.
- Mutations in the non-structural 5A protein's IFN sensitivity-determining region (ISDR) have been linked to sustained virological response (SVR).
- IL-8 is implicated in the inhibition of IFN-α's antiviral effects.
Purpose of the Study:
- To investigate the impact of pretreatment ISDR mutations and hepatic IL-8 mRNA expression on SVR rates in Hepatitis C virus (HCV) genotype 1b patients receiving combination therapy.
- To determine if IL-8 expression and ISDR mutations are predictive biomarkers for treatment outcome.
Main Methods:
- A cohort of 53 HCV-1b patients who completed 24 weeks of pegylated-IFN-α2b plus ribavirin therapy and follow-up were analyzed.
- Liver biopsies were obtained within 6 months prior to therapy for analysis.
- Hepatic IL-8 mRNA expression was quantified using real-time reverse transcriptase PCR.
Main Results:
- 30 out of 53 patients achieved SVR.
- Multivariate analysis identified hepatic IL-8 mRNA expression <1.5×10(-4) (OR 6.66) and ISDR mutations ≥4 (OR 12.20) as independent predictors of SVR.
- Fibrosis scores and alanine aminotransferase levels predicted hepatic IL-8 mRNA expression (r(2)=0.204).
Conclusions:
- Down-regulated hepatic IL-8 mRNA expression and the presence of ISDR mutations are associated with successful SVR to combination therapy in Hepatitis C 1b patients.
- Hepatic IL-8 mRNA expression levels are influenced by fibrosis scores and alanine aminotransferase levels.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Non-LTR Retrotransposons
Viral Hepatitis I: Introduction
Leaky Scanning

